Literature DB >> 11281079

Discontinuing antidepressants and benzodiazepines upon becoming pregnant. Beware of the risks of abrupt discontinuation.

A Einarson1, P Selby, G Koren.   

Abstract

QUESTION: Two of my patients are planning to become pregnant. One is taking paroxetine and the other lorazepam. We have discussed what to do when they become pregnant and have decided they should stop taking these drugs as soon as pregnancy is confirmed. Is this the right decision? ANSWER: The decision to discontinue these drugs during pregnancy should be based on scientific evidence rather than "hearsay" that women should not take psychotropic medications during pregnancy. Recent epidemiologic studies have documented the relative safety of these drugs, so women should not feel compelled to stop taking them when they become pregnant. If, after receiving appropriate evidence-based information, a woman decides to stop taking the drugs, they should be gradually tapered off to avoid abrupt discontinuation syndrome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11281079      PMCID: PMC2018402     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  15 in total

1.  [Two cases of psychotic state following normal-dose benzodiazepine withdrawal].

Authors:  T Terao; Y Tani
Journal:  J UOEH       Date:  1988-09-01

2.  Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study.

Authors:  N A Kulin; A Pastuszak; S R Sage; B Schick-Boschetto; G Spivey; M Feldkamp; K Ormond; D Matsui; A K Stein-Schechman; L Cook; J Brochu; M Rieder; G Koren
Journal:  JAMA       Date:  1998-02-25       Impact factor: 56.272

3.  Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation.

Authors:  K Rickels; E Schweizer; W G Case; D J Greenblatt
Journal:  Arch Gen Psychiatry       Date:  1990-10

4.  Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling.

Authors:  A Einarson; P Selby; G Koren
Journal:  J Psychiatry Neurosci       Date:  2001-01       Impact factor: 6.186

5.  Pregnancy outcome following gestational exposure to echinacea: a prospective controlled study.

Authors:  M Gallo; M Sarkar; W Au; K Pietrzak; B Comas; M Smith; T V Jaeger; A Einarson; G Koren
Journal:  Arch Intern Med       Date:  2000-11-13

6.  Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.

Authors:  J F Rosenbaum; M Fava; S L Hoog; R C Ascroft; W B Krebs
Journal:  Biol Psychiatry       Date:  1998-07-15       Impact factor: 13.382

7.  Death following suspected alprazolam withdrawal seizures: a case report.

Authors:  W Haque; D J Watson; S G Bryant
Journal:  Tex Med       Date:  1990-01

Review 8.  Benzodiazepine dependence: management of discontinuation.

Authors:  K Rickels; W G Case; E Schweizer; F Garcia-Espana; R Fridman
Journal:  Psychopharmacol Bull       Date:  1990

9.  Mania induced by lorazepam withdrawal: a report of two cases.

Authors:  D Turkington; P Gill
Journal:  J Affect Disord       Date:  1989 Jul-Aug       Impact factor: 4.839

View more
  4 in total

1.  Update on motherisk updates. Seven years of questions and answers.

Authors:  Adrienne Einarson; Galina Portnoi; Gideon Koren
Journal:  Can Fam Physician       Date:  2002-08       Impact factor: 3.275

2.  Is a fetus a non-consenting patient?

Authors:  Gideon Koren; Peter Selby; Bhushan Kapur
Journal:  Can Fam Physician       Date:  2004-09       Impact factor: 3.275

3.  Depression during Pregnancy : Overview of Clinical Factors.

Authors:  Heather A Bennett; Adrienne Einarson; Anna Taddio; Gideon Koren; Thomas R Einarson
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

Review 4.  Treatment of opioid-dependent pregnant women: clinical and research issues.

Authors:  Hendree E Jones; Peter R Martin; Sarah H Heil; Karol Kaltenbach; Peter Selby; Mara G Coyle; Susan M Stine; Kevin E O'Grady; Amelia M Arria; Gabriele Fischer
Journal:  J Subst Abuse Treat       Date:  2008-01-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.